31 steps to a smoother heart bypass recovery

NCT ID NCT07817264

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are testing whether a structured Enhanced Recovery After Surgery (ERAS) program improves recovery for people having their first coronary artery bypass graft. The program bundles 31 care steps before, during, and after surgery, including patient education, nutrition support, pain control, and early mobilization. Fifty participants having off-pump bypass surgery are randomly assigned to receive the ERAS protocol or standard care. The trial measures recovery quality and symptom severity to see if the program makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced Recovery After Surgery (ERAS) protocol, a structured set of 31 perioperative care steps
What this could lead to
If it works, this could give heart surgery teams a standard recovery plan that shortens hospital stays and helps patients feel better sooner.
What could go wrong
The trial is small, with 50 participants at one center, so results may not apply to all heart surgery patients. ERAS programs also require strict coordination, and any single step could be hard to follow consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Oct 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being admitted for their first planned coronary artery bypass graft (CABG) surgery; * Undergoing off-pump coronary artery bypass (OPCAB) surgery without the use of a cardiopulmonary bypass machine; * Not undergoing any additional surgical procedure during CABG surgery; * Having no abnormalities in preoperative laboratory parameters, including hemoglobin, albumin, and electrolytes; * Having no cognitive impairment; * Having no psychological or mental disorder; * Being able to speak Turkish and communicate effectively; * Being at least literate; * Being 18 years of age or older; * Being reachable by telephone during the follow-up period; and * Providing informed consent to participate in the study. Exclusion Criteria: * Having previously undergone CABG surgery; * Undergoing CABG surgery using cardiopulmonary bypass with the heart arrested; * Undergoing any additional surgical procedure during CABG surgery; * Having electrolyte abnormalities in preoperative laboratory parameters; * Having cognitive impairment; * Having a psychological or mental disorder; * Being unable to speak Turkish, communicate effectively, or provide consent to participate in the study; * Being unable to read and write; * Being younger than 18 years of age; * Being unreachable by telephone during the follow-up period; * Withdrawing from the study after initially agreeing to participate; * Undergoing any surgical operation after hospital admission; or * Dying during the study intervention or follow-up period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bolu Abant İzzet Baysal University İzzet Baysal Training and Research Hospital

    Bolu, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.